# INTERVIEW: Deltex Medical Group Plc Good growth and new product launches soon

- Link: https://www.directorstalkinterviews.com/interview-deltex-medical-group-plc-good-growth-new-product-launches-soon/412727993
- Published: 2017-04-28T11:24:13+01:00
- Author: Giles Arbor

**Deltex Medical Group Plc** (LON:DEMG) CEO Ewan Phillips talks to DirectorsTalk
about its results for the year ended 31st Dec 2016 and also the award of a grant
under the EU’s Horizon 2020 programme. Ewan talks us through the highlights, provides
more detail around the grant, talks us through some new products that will be launched
very soon and explains what reaching the 30 account platform target has meat for
the company and company resources are to be redeployed to best serve its American
customer base.

 

Deltex Medical Group Plc manufactures and markets haemodynamic monitoring technologies.
Deltex Medical’s ODM is the only technology to measure continuously blood flow in
the central circulation in real time. Minimally invasive, easy to set up and quick
to focus, the technology generates a low-frequency ultrasound signal, which is highly
sensitive to changes in flow and measures them immediately. Deltex has been the 
only company in the enhanced haemodynamic space to build a robust and credible evidence
base proving the clinical and economic benefits of its core technology, ODM. Randomised,
controlled trials using Doppler have demonstrated that early fluid management intervention
will reduce post-operative complications, reduce intensive care admissions, and 
reduce the length of hospital stay.

Share on:
